미숙아 동맥관 개존증의 예방적 치료로서 Indomethacin과 Ibuprofen의 효과
Effects of Ibuprofen and Indomethacin for Prophylaxis of Patent Ductus Arteriosus in Premature Infants
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
목적: Indomethacin은 미숙아 동맥관 개존증의 예방적 용법및 치료적 용법에 사용되어 왔다. 하지만 최근에는 indomethacin의국내 보급이 중단됨에 ibuprofen이 사용되고 있다. Ibuprofen은 동맥관 폐쇄에 indomethacin만큼 효과적이며 부작용은 적은 것으로 알려져 있다. 그러나 ibuprofen의 예방적용법에 관한 연구는 많지 않다. 본 연구에서는 미숙아에서 동맥관 개존증의 예방적 치료에 대한 ibuprofen의 효과와 안정성을indomethacin과 비교하여 분석하고자 하였다. 방법: 2009년 1월부터 2009년 12월, 그리고 2010년 1월부터2011년 2월까지 두 기간동안 3개의 참여 대학병원 신생아 중환자실에 입원한 34주 미만, 1,500 g 미만의 신생아 중에서 생후24시간 이내에 indomethacin이나 ibuprofen이 예방적 목적으로 투여된 환자를 대상으로 하여 의무기록을 후향적으로 검토하였다. 두 군간의 동맥관 폐쇄에 대한 효과와 주산기 합병증의발생 정도를 조사하였다. 결과: 두 군간에 환아의 성별, 재태 연령, 출생체중, 분만 방법,1분 및 5분 Apgar 점수, 산모의 steroid 사용 여부, 폐 표면활성제 사용 여부 및 인공호흡기 사용여부 및 사용기간에 있어 유의한 차이는 없었다. 생후 7일에 시행한 심초음파 검사에서indomethacin군은 17명 중 13명, ibuprofen군은 20명 중 19명이 동맥관의 폐쇄를 보였다. 총 입원 기간 외에 주산기 합병증의빈도는 두 군간의 유의한 차이가 없었다. 결론: Ibuprofen의 예방적 사용은 동맥관 폐쇄에 효과적이며주산기 합병증 측면에서 유의한 부정적인 차이가 없었다. 따라서 indomethacin을 대체하여 ibuprofen의 사용을 고려해 볼수 있겠다.
Abstract
Purpose: The aim of our study was to compare the efficacy and safety of ibuprofen and indomethacin in the prophylaxis of patent ductus arteriosus (PDA) in preterm infants and to determine whether ibuprofen could be an alternative agent in prophylactic use. Methods: A retrospective study including 37 preterm infants <1,500 g of birth weight, <34 weeks of gestation, whom were administrated indomethacin (n=17; January 2009-December 2009) or ibuprofen (n=20; January 2010-February 2011) within 24 hr after birth was conducted. The rate of ductal closure, need for surgical ligation, clinical outcomes such as necrotizing enterocolitis,intraventricular hemorrhage, bronchopulmonary dysplasia, retinopathy of prematurity (ROP) and death rate were compared. Results: There were no statistically significant differences between the two groups in mean gestational age, mean birth weight,Apgar score, sex, type of delivery, maternal dexamethasone treatment, frequency and duration of ventilator and surfactant treatment. The closure of PDA on day 7 of life was in 19 of 20 infants of the ibuprofen group and 13 of 17 infants of the indomethacin group (P=0.159). Between the two groups, there were no significant differences with respect to clinical outcomes. Conclusion: Ibuprofen has similar effects to indomethacin in the rate of PDA closure. Our study demonstrates that prophylactic ibuprofen is relatively effective without significant differences with respect to clinical outcomes compared with indomethacin. Therefore, ibuprofen may be used as an alternative agent in the prophylaxis of PDA in preterm infants.
참고문헌 (31)
- Hammerman C, "Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment", Clin Perinatol, 22, pp.457~479 (1995)
- Farstad T, "Pulmonary effects of closure of patent ductus arteriosus in premature infants with severe respiratory distress syndrome", Eur J Pediatr, 153, pp.903~905 (1994)
- Wyllie J, "Treatment of patent ductus arteriosus", Semin Neonatol, 8, pp.425~432 (2003)
- Coceani F, "The response of the ductus arteriosus to prostaglandins", Can J Physiol Pharmacol, 51, pp.220~225 (1973)
- Friedmann WF, "Pharmacologic closure of patent ductus arteriosus in the premature infant", N Engl J Med, 295, pp.526~529 (1976)
- Van Bel F, "Indomethacin- induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging", J Pediatr, 118, pp.621~626 (1991)
- Van Bel F, "Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants", J Pediatr, 116, pp.965~970 (1990)
- Edwards AD, "Effects of indomethacin on cerebral haemodynamics in very preterm infants", Lancet, 335, pp.1491~1495 (1990)
- Coceani F, "Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen", Can J Physiol Pharmacol, 57, pp.825~831 (1979)
- Van Overmeire B, "A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus", N Engl J Med, 343, pp.674~681 (2000)
- Patel J, "Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus", Pediatr Res, 47, pp.36~42 (2000)
- Romagnoli C, "Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates", Clin Pharmacol Ther, 67, pp.676~683 (2000)
- Pezzati M, "Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus", J Pediatr, 135, pp.733~738 (1999)
- Stefano JL, "Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation", Am Rev Respir Dis, 143, pp.236~239 (1991)
- Merritt TA, "Early closure of the patent ductus arteriosus in very lowbirth- weight infants: a controlled trial", J Pediatr, 99, pp.281~286 (1981)
- Overturf GD, "Focal bacterial infection. In Infectious disease of the fetus and newborn infants. 5th ed", pp.1058~1063 (2001), Philadelphia : WB Saunders Co
- Papile LA, "Incidence and evolution of subependymal and intraventricular hemorrhage : a study of infants with birth weights less than 1,500 gm", J Pediatr, 92, pp.529~534 (1978)
- "An international classification of retinopathy of prematurity. II. The classification of retinal detachment", Arch Ophthalmol, 105, pp.906~912 (1987), The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity
- Jobe AH, "Bronchopulmonary dysplasia", Am J Respire Crit Care Med, 163, pp.1723~1729 (2001)
- Drummond WH, "Ductus arteriosus. In Intensive care of the fetus and neonate. 2nd ed", pp.760~761 (1996), Louis: CV Mosby Co
- Perlman JM, "The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries : ductal steal in the premature newborn infant", J Pediatr, 99, pp.767~771 (1981)
- Mosca F, "Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus", J Pediatr, 131, pp.549~554 (1997)
- Patel J, "Ibuprofen treatment of patent ductus arteriosus", Lancet, 346, pp.255~ (1995)
- Van Overmeire B, "Treatment of patent ductus arteriosus with ibuprofen", Arch Dis Child Fetal Neonatal Ed, 76, pp.F179~F184 (1997)
- Gournay V, "Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial", Lancet, 364, pp.1939~1944 (2004)
- Shah SS, "Ibuprofen for the prevention of patent ductus arteriosus in preterm and", or low birth weight infants, pp.203(2), CD004213~
- Dani C, "Prophylaxis of patent ductus arteriosus with ibuprofen in preterm Infants", Acta Pediatr, 89, pp.1369~1374 (2000)
- De Carolis MP, "Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants", Eur J Pediatr, 159, pp.364~368 (2000)
- Seok EJ, "Effect of indomethacin therapy on prevention of intraventricular hemorrhage in very low birth weight infant", J Korean Soc Neonatol, 5, pp.27~34 (1998)
- Seo JY, "The factors associated with oliguria after indomethacin administration in preterm infants with patent ductus arteriosus", J Korean Soc Neonatol, 9, pp.65~73 (2002)
- 이수진, "호흡곤란 증후군 미숙아에서 동맥관 개존증의 약물 치료 : 경구용 ibuprofen과 indomethacin의 비교", Korean Journal of Pediatrics, 51(9), pp.956~963 (2008), 대한소아과학회